Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Aerpio Pharmaceuticals, Inc. ARPO

Set alert

Price alert · ARPO

All alert types
2.20 0.00 0.00%

At close

2.16 Day range 2.30

52-week range unavailable

Open
2.22
Prev close
2.20
Mkt cap
104.85M
Vol
826.01K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.16
High
2.30
Forward P/E
-1.21
Beta
1.65
Short ratio
1.81
Inst. own
71.05%
Dividend
0.00
Ex-div date
Earnings
Aug 11, 2021
50-d avg
31.63
200-d avg
25.85
1y target
22.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ARPO has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.18 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -6.7×
FY 2017: -1.7×FY 2018: -0.5×FY 2019: -0.3×FY 2020: -0.7×FY 2021: -2.3×FY 2022: -2.0×FY 2024: -0.9×FY 2025: -6.7×
FY 2017 5y median -2.0× FY 2025
P/S 191×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 19.5×FY 2021: 11.9×FY 2022: 13.7×FY 2024: 2.3×FY 2025: 191×
FY 2017 5y median 13.7× FY 2025
P/B 10.0×
FY 2017: 1.1×FY 2018: 1.0×FY 2019: 0.3×FY 2020: 0.9×FY 2021: 2.1×FY 2022: 2.1×FY 2024: 1.1×FY 2025: 10.0×
FY 2017 5y median 2.1× FY 2025
P/FCF -13.9×
FY 2017: -1.8×FY 2018: -0.7×FY 2019: -0.3×FY 2020: -0.8×FY 2021: -2.1×FY 2022: -2.2×FY 2024: -1.0×FY 2025: -13.9×
FY 2017 5y median -2.1× FY 2025
EV/EBITDA -11.6×
FY 2017: -1.1×FY 2018: 0.2×FY 2019: 0.1×FY 2020: -0.3×FY 2021: -1.9×FY 2022: -1.7×FY 2024: -0.5×FY 2025: -11.6×
FY 2017 5y median -1.7× FY 2025
EV/Sales 185×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 7.8×FY 2021: 9.6×FY 2022: 11.0×FY 2024: 1.2×FY 2025: 185×
FY 2017 5y median 9.6× FY 2025
FCF Yield -7.2%
FY 2017: -54.8%FY 2018: -145.4%FY 2019: -331.7%FY 2020: -118.7%FY 2021: -46.9%FY 2022: -46.0%FY 2024: -102.9%FY 2025: -7.2%
FY 2017 5y median -46.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -1655.0%FY 2021: -347.4%FY 2022: -535.7%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median -347.4% FY 2025
Operating Margin -1601.1%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2623.0%FY 2021: -532.5%FY 2022: -670.8%FY 2024: -259.6%FY 2025: -1601.1%
FY 2017 5y median -670.8% FY 2025
Net Margin -288.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2695.1%FY 2021: -517.5%FY 2022: -670.2%FY 2024: -245.1%FY 2025: -288.3%
FY 2017 5y median -517.5% FY 2025
ROE -15.1%
FY 2017: -62.1%FY 2018: -217.1%FY 2019: -133.5%FY 2020: -117.6%FY 2021: -91.2%FY 2022: -102.3%FY 2024: -121.4%FY 2025: -15.1%
FY 2017 5y median -102.3% FY 2025
ROIC -83.9%
FY 2017: -63.2%FY 2018: -94.1%FY 2019: -189.7%FY 2020: -105.5%FY 2021: -46.0%FY 2022: -70.6%FY 2024: -126.1%FY 2025: -83.9%
FY 2017 5y median -83.9% FY 2025
ROA -13.7%
FY 2017: -57.6%FY 2018: -114.8%FY 2019: -76.5%FY 2020: -56.1%FY 2021: -33.2%FY 2022: -38.5%FY 2024: -90.6%FY 2025: -13.7%
FY 2017 5y median -38.5% FY 2025

Growth (YoY)

Revenue -72.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 443.6%FY 2022: 23.1%FY 2024: 0.0%FY 2025: -72.5%
FY 2017 FY 2025
Operating Income -69.6%
FY 2017: 0.0%FY 2018: 29.5%FY 2019: -65.2%FY 2020: -20.0%FY 2021: -10.4%FY 2022: -55.1%FY 2024: 0.0%FY 2025: -69.6%
FY 2017 FY 2025
EPS (diluted) 86.0%
FY 2017: 0.0%FY 2018: -59.6%FY 2019: 32.3%FY 2020: 44.4%FY 2021: 28.9%FY 2022: -12.5%FY 2024: 0.0%FY 2025: 86.0%
FY 2017 FY 2025
Free Cash Flow -60.1%
FY 2017: 0.0%FY 2018: 20.1%FY 2019: -37.4%FY 2020: -20.8%FY 2021: -30.3%FY 2022: -39.4%FY 2024: 0.0%FY 2025: -60.1%
FY 2017 FY 2025

Financial Health

Current Ratio 10.3×
FY 2017: 28.2×FY 2018: 5.1×FY 2019: 1.4×FY 2020: 1.6×FY 2021: 3.1×FY 2022: 1.1×FY 2024: 3.6×FY 2025: 10.3×
FY 2017 5y median 3.1× FY 2025
Quick Ratio 10.3×
FY 2017: 28.2×FY 2018: 5.1×FY 2019: 1.4×FY 2020: 1.6×FY 2021: 3.1×FY 2022: 1.1×FY 2024: 3.3×FY 2025: 10.3×
FY 2017 5y median 3.1× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 0.8×FY 2018: 1.0×FY 2019: 0.4×FY 2020: 0.5×FY 2021: 0.5×FY 2022: 0.4×FY 2024: 0.4×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 438×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31